A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 12884193)

Published in Liver Transpl on August 01, 2003

Authors

Antonino Cavallari1, Umberto Cillo, Bruno Nardo, Franco Filipponi, Enrico Gringeri, Roberto Montalti, Fabio Vistoli, Francesco D'amico, Antonio Faenza, Franco Mosca, Alessandro Vitale, Davide D'amico

Author Affiliations

1: Dipartimento di Discipline Chirurgiche, Rianimatorie e dei Trapianti Policlinico S Orsola, University of Bologna, Italy.

Articles by these authors

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93

Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology (2010) 3.53

Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A (2007) 3.11

Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol (2006) 3.09

Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes (2002) 2.58

Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes (2005) 2.47

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. Cancer Res (2006) 2.38

Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol (2008) 2.36

Biased incorporation of ribonucleotides on the mitochondrial L-strand accounts for apparent strand-asymmetric DNA replication. Cell (2002) 2.32

Ovarian metastasis from colorectal cancer: prognostic value of radical oophorectomy. J Surg Oncol (2007) 2.25

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol (2004) 2.18

When to perform hepatic resection for intermediate-stage hepatocellular carcinoma. Hepatology (2015) 2.15

Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg (2009) 2.11

Long-term outcome of bone mineral density in children who underwent a successful liver transplantation. Transplantation (2004) 2.04

Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. Lancet Oncol (2011) 2.04

A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transpl (2007) 2.01

Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg (2002) 1.95

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg (2004) 1.88

Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int (2012) 1.87

Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol (2006) 1.87

Subnormothermic machine perfusion protects steatotic livers against preservation injury: a potential for donor pool increase? Liver Transpl (2009) 1.75

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl (2007) 1.68

Impairment of mitochondrial oxidative phosphorylation in rat fatty liver exposed to preservation-reperfusion injury. J Hepatol (2004) 1.67

Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab (2004) 1.66

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59

First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation. Transplantation (2010) 1.58

ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy. Liver Transpl (2006) 1.57

Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons. Kidney Int (2010) 1.57

Influence of steroids on HCV recurrence after liver transplantation: A prospective study. J Hepatol (2007) 1.56

Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. J Hepatol (2012) 1.56

Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis (2010) 1.54

The survival benefit of liver transplantation in hepatocellular carcinoma patients. Dig Liver Dis (2010) 1.53

12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Liver Transpl (2006) 1.53

Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD. Liver Transpl (2007) 1.52

Cost and outcome analysis and cost determinants of liver transplantation in a European National Health Service hospital. Transplantation (2003) 1.50

Use of N-acetylcysteine during liver procurement: a prospective randomized controlled study. Liver Transpl (2012) 1.49

Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible? Liver Transpl (2014) 1.46

Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol (2011) 1.46

"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases. Dig Liver Dis (2012) 1.45

Religiosity associated with prolonged survival in liver transplant recipients. Liver Transpl (2010) 1.44

Use of fenoldopam to control renal dysfunction early after liver transplantation. Liver Transpl (2004) 1.44

Feasibility and limits of split liver transplantation from pediatric donors: an italian multicenter experience. Ann Surg (2006) 1.43

Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42

Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis. World J Surg (2015) 1.42

Segmental live donor pancreas transplantation: review and critique of rationale, outcomes, and current recommendations. Clin Transplant (2010) 1.42

Liver transplantation using suboptimal grafts: impact of donor harvesting technique. Liver Transpl (2007) 1.41

Skin cancer and other cutaneous disorders in liver transplant recipients. Acta Derm Venereol (2012) 1.41

Laparoscopic radiofrequency ablation in the caudate lobe for hepatocellular carcinoma before liver transplantation. J Laparoendosc Adv Surg Tech A (2012) 1.40

Laparoscopy-assisted abdominal aortic aneurysm repair: early and middle-term results of a consecutive series of 122 cases. J Vasc Surg (2006) 1.40

Identification of the protein storage vacuole and protein targeting to the vacuole in leaf cells of three plant species. Plant Physiol (2004) 1.36

Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology (2007) 1.34

Lipotoxicity in human pancreatic islets and the protective effect of metformin. Diabetes (2002) 1.34

Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg (2012) 1.34

Intra-abdominal pressure monitoring in liver transplant recipients: a prospective study. Intensive Care Med (2002) 1.28

Giant splenic epithelial cyst with elevated serum markers CEA and CA 19-9 levels: an incidental association? Anticancer Res (2003) 1.20

Robot assistance in liver surgery: a real advantage over a fully laparoscopic approach? Results of a comparative bi-institutional analysis. Int J Med Robot (2013) 1.19

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl (2009) 1.18

Zeolin. A new recombinant storage protein constructed using maize gamma-zein and bean phaseolin. Plant Physiol (2004) 1.17

Laparoscopic treatment of splenic artery aneurysms. J Vasc Surg (2009) 1.13

Hepatic resection for primary or secondary malignancies with involvement of the inferior vena cava: is this operation safe or hazardous? J Am Coll Surg (2005) 1.11

Robotic renal transplantation: first European case. Transpl Int (2010) 1.11

Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care (2005) 1.09

Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer (2012) 1.07

Prognostic prediction and identification of candidates for salvage liver transplantation among patients with early hepatocellular carcinoma. Liver Transpl (2014) 1.07

Insulin secretory function is impaired in isolated human islets carrying the Gly(972)-->Arg IRS-1 polymorphism. Diabetes (2002) 1.07

Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer. Surgery (2009) 1.06

Effects of pancreas-kidney transplantation on diabetic retinopathy. Transpl Int (2005) 1.06

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06

Postoperative intra-abdominal pressure and renal function after liver transplantation. Arch Surg (2003) 1.06

Laparoscopic pancreaticoduodenectomy: a systematic literature review. Surg Endosc (2014) 1.05

The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J Surg Res (2005) 1.05

The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur J Endocrinol (2006) 1.04

The value of laparoscopic liver surgery for solid benign hepatic tumors. Surg Endosc (2007) 1.03

Single-session percutaneous ethanol ablation of early-stage hepatocellular carcinoma with a multipronged injection needle: results of a pilot clinical study. J Vasc Interv Radiol (2010) 1.03

Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg (2002) 1.03

Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. Dig Liver Dis (2013) 1.02

Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl (2009) 1.02

Traffic routes and signals for the tonoplast. Traffic (2013) 1.01

Retention of a bean phaseolin/maize gamma-Zein fusion in the endoplasmic reticulum depends on disulfide bond formation. Plant Cell (2006) 1.00

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study. J Hepatol (2008) 1.00

Robotic suture of a large caval injury caused by endo-GIA stapler malfunction during laparoscopic wedge resection of liver segments VII and VIII en-bloc with the right hepatic vein. Minim Invasive Ther Allied Technol (2009) 1.00